Cannabis producers are among the least reputable corporations in the eyes of Canadians – ranking alongside petroleum companies and others – largely because they remain unknown to the general public, according to a new survey measuring the reputations of nearly 300 businesses operating in Canada.
Matt Lamers
Matt Lamers's Latest Posts
Canadian cannabis retailer Choom granted creditor protection
Struggling Canadian cannabis retailer Choom Holdings and its subsidiaries received an order for creditor protection from the Supreme Court of British Columbia.
Cannabis producer Canopy Growth sheds 8% of workforce, eyes CA$150 million more in savings
Canadian cannabis producer Canopy Growth slashed approximately 8% of its workforce Tuesday as part of sweeping changes across the company designed to help stem recent losses and nudge the struggling company to profitability, MJBizDaily has learned.
Decibel books CA$1.7 million profit on rising cannabis sales
Decibel Cannabis Co. recorded net income of 1.7 million Canadian dollars ($1.3 million) for the 2021 fiscal year and positive adjusted EBITDA of CA$7.4 million on the back of growing cannabis sales.
Hexo closing Belleville cannabis facility, laying off another 230 workers
Struggling Canadian cannabis producer Hexo Corp. is closing its Belleville facility and transitioning its operations to other sites as part of a “strategic plan” to become cash-flow positive from operations.
Switzerland aims for summer start of recreational cannabis trial program
Europe’s latest recreational cannabis trial program is set to begin in Basel, Switzerland, this summer.
Health Canada referred almost 500 cannabis-related cases to federal police over 2-year period
Health Canada referred nearly 500 cannabis business-related cases to the Royal Canadian Mounted Police (RCMP) for possible enforcement action during the two years ending in March 2021, a major increase over fiscal year 2018-19.
Cannabis producer Organigram reports modest positive adjusted EBITDA
Organigram reported positive adjusted EBITDA of 1.6 million Canadian dollars ($1.27 million) on the back of growing international medical cannabis sales in the second quarter, marking a key milestone for the Moncton, New Brunswick, producer.
GlaxoSmithKline unit inks CBD pill deal with marijuana company Cann
Cann Group Limited, an Australian cannabis producer, said it has entered into an exclusive evaluation and option deal with GSK Consumer Healthcare, a subsidiary of U.K. drugmaker GlaxoSmithKline.
Tilray reports positive adjusted EBITDA, but cannabis sales fall sharply
Tilray reported positive adjusted EBITDA of $10 million (12.5 million Canadian dollars) for the three months ended Feb. 28, about 24% lower than the previous quarter after its cannabis sales tumbled to $55 million in the three-month period.
Labatt shutters CBD beverage unit in Canada in latest blow to category
Labatt Breweries of Canada, one of the country’s top beer makers, pulled the plug on its nonalcoholic CBD beverage unit in Canada, Fluent Beverages, signaling continued pressure on the nation’s fledgling infused-drinks category.
Canada streamlining application process to get cannabis to market quicker
Canada’s federal cannabis regulator is streamlining the application process to reduce the regulatory burden facing standard and micro-class marijuana processing license holders, a move that’s intended to give new and existing licensees the ability to bring products to market more quickly.













